Company / Total Debt
Collegium Pharmaceutical, Inc. Total Debt History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$11.5M
FY2019
5-year range
-
FY2016-FY2019
Trend
+0.0%
vs FY2018
Sector context
#78 of 83
Health Care
What the data says
Among 83 Health Care companies, Collegium Pharmaceutical, Inc. is in the top 6% for total debt. Increased from $4M to $12M over the past 3 years.
Based on SEC 10-K filings.
$12M in FY2019.
Increased from $4M to $12M over the past 3 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +40.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 83This company $11.5M Sector average $6.2B
▼
-99.8% below sector average
Key checks
Key Insights
- 3-year CAGR of +40.5%, indicating consistent growth.
- In FY2019, total debt increased 0.0% year-over-year.
- Ranks #78 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $11.5M | +0.0% |
| FY2018 | $11.5M | - |
| FY2017 | - | - |
| FY2016 | $4.1M | - |
As of FY2019 · SEC 10-K · Updated Jul 2, 2026